Home/Filings/4/0001628280-23-008610
4//SEC Filing

Koenig Sheldon L. 4

Accession 0001628280-23-008610

CIK 0001434868other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:16 PM ET

Size

4.8 KB

Accession

0001628280-23-008610

Insider Transaction Report

Form 4
Period: 2023-03-17
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2023-03-17$1.78/sh6,999$12,479292,816 total
Footnotes (1)
  • [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001766524

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:16 PM ET
Size
4.8 KB